Tissue factor pathway inhibitor can interact with platelets

被引:3
|
作者
Nishioka, T [1 ]
Yokota, M [1 ]
Hino, M [1 ]
Tsuda, I [1 ]
Tatsumi, N [1 ]
机构
[1] Osaka City Univ, Sch Med, Dept Clin Lab & Med, Abeno Ku, Osaka 5458585, Japan
关键词
tissue factor pathway inhibitor; platelet aggregation; GPIIb/IIIa;
D O I
10.1016/S0022-1759(02)00145-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tissue factor pathway inhibitor (TFPI) regulates the extrinsic pathway of blood coagulation. However, there is no report on interaction between TFPI and platelets other than that by Tsuji, who found that whole blood anticoagulated with TFPI exhibited remarkable decrease in platelet count. Our study revealed that washed platelets suspended in modified Tyrode's buffer (8 mM CaCl2) containing TFPI exhibit platelet aggregation. However, platelets aggregation was observed without TFPI, but its increase and intensity were slow and weak, compared to that in the presence of TFPI. This aggregation was inhibited by anti-CD41 (anti-GPIIb) antibody. This finding suggested that TFPI promotes platelet aggregation. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:181 / 184
页数:4
相关论文
共 50 条
  • [31] Regulation of tissue factor signaling by tissue factor pathway inhibitor.
    Ahamed, J
    Belting, M
    Ruf, W
    BLOOD, 2004, 104 (11) : 533A - 533A
  • [32] The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis
    Levi, M
    CRITICAL CARE MEDICINE, 2002, 30 (08) : 1914 - 1915
  • [33] Tissue factor pathway inhibitor-2 may interact with nuclear protein RASSF1C
    Chen, Xudong
    Li, Zhenwu
    Zhang, Jin
    Mao, Zuohua
    Ma, Duan
    Wang, Huijun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2012, 44 (02) : 183 - 185
  • [34] Platelets Contain Tissue Factor Pathway Inhibitor-2 Derived from Megakaryocytes and Inhibits Fibrinolysis
    Vadivel, Kanagasabai
    Ponnuraj, Sathya-Moorthy
    Kumar, Yogesh
    Zaiss, Anne K.
    Bunce, Matthew W.
    Camire, Rodney M.
    Wu, Ling
    Evseenko, Denis
    Herschman, Harvey R.
    Bajaj, Madhu S.
    Bajaj, S. Paul
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (45) : 31647 - 31661
  • [35] Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?
    Dahm, Anders Erik Astrup
    Sandset, Per Morten
    BLOOD ADVANCES, 2021, 5 (11) : 2516 - 2517
  • [36] Tissue factor pathway inhibitor and haemophilia.
    Kubisz, P
    Ivanková, J
    Snopek, I
    BLOOD, 1998, 92 (10) : 95B - 95B
  • [37] TISSUE FACTOR PATHWAY INHIBITOR IN INFANTS AND CHILDREN
    WEISSBACH, G
    HARENBERG, J
    WENDISCH, J
    PARGAC, N
    THOMAS, K
    THROMBOSIS RESEARCH, 1994, 73 (06) : 441 - 446
  • [38] TISSUE FACTOR PATHWAY INHIBITOR IN HEALTH AND DISEASE
    LINDAHL, AK
    TRENDS IN CARDIOVASCULAR MEDICINE, 1995, 5 (04) : 167 - 171
  • [39] THE PRESENT STATUS OF TISSUE FACTOR PATHWAY INHIBITOR
    LINDAHL, AK
    SANDSET, PM
    ABILDGAARD, U
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 439 - 449
  • [40] REPEATED RELEASE OF THE TISSUE FACTOR PATHWAY INHIBITOR
    ARIENS, RAS
    FAIONI, EM
    MANNUCCI, PM
    THROMBOSIS AND HAEMOSTASIS, 1994, 72 (02) : 327 - 328